Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Phibro PAHC Stock Smart Investment Investor Interest 20260420 RSKD Riskified beats Q4 2025 EPS expectations by 193 percent shares post mild gains after earnings release Charter Communications CHTR BrightSpring BTSG Stock Is It a Good Buy BrightSpring EPS misses analyst estimates by 76 Digital Realty Trust Inc DLR Bullish PreEarnings Tailwinds Following Peer Prologis Strong Q1 2026 Results What PMV Pharmaceuticals PMVP is doing to earn customer loyalty Smart Money Outflows 20260508 IRHOR Iron Horse latest quarterly earnings filing omits core financial metrics and formal forward guidance Invesco QQQ Trust QQQ Tempus AI TEM Catalyst Preview Ahead of Q1 2026 Earnings Release Baidu Inc BIDU Announces 2026 Annual General Meeting Date Publishes 2025 FullYear Regulatory Filings Stifel SF Q1 2026 Earnings 145 EPS Surges Past 144 Estimates Inter INTR Slides 272 as Selling Pressure Mounts 20260515 Tailwind TDWDR Stock Steady at 012 Support at 011 20260518 Hyperfine HYPR Gains 057 Support Holds at 152 20260514 Gift Nifty Hints at Optimistic Start for Indian Equities Amid Global Market Cues Xencor XNCR Q1 2026 Underperforms Key Challenges Ahead Pessimism Persists US Consumer Confidence Stuck at Record Lows as Economic Shocks Accumulate Amicus Therapeutics FOLD Q4 2025 Earnings EPS Misses Estimates Revenue Not Disclosed Shares Unchanged CYRX Q1 2026 Earnings EPS Miss Reflects Persistent Cost Pressures HMR Q1 2026 Earnings EPS Beats Estimates by Over 1000 but Stock Tumbles 20 CVKD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline COE Q3 2025 Earnings Loss Per Share Reported Stock Declines Despite No Revenue Disclosure GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly Gentex Corporation GNTX Edges Higher Testing Key Resistance at 2524 ColgatePalmolive CL Edges Higher as Defensive Appeal Strengthens BrightSpring Health Services BTSG Holds Near Resistance Signaling Caution NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support